Company Overview and News


Add 1099
to your dashboard

Headline News

Walgreens agrees 2.76 billion yuan deal with China’s largest health care retailer for pharmacy stake

2017-12-06 scmp
Global pharmacy and health care company Walgreens Boots Alliance said on Wednesday it had signed an agreement with Sinopharm Group, China’s largest retailer of pharmaceutical and health care products, in a deal worth 2.76 billion yuan (US$417 million). (2-0)

Hong Kong’s Hang Seng breaks through 30,000 points, hits decade high

2017-11-22 thehindubusinessline
Hong Kong's benchmark Hang Seng Index broke through the 30,000 point-mark on Wednesday for the first time in 10 years, amid signs Chinese investors are stepping up buying Hong Kong blue chips such as Tencent. China stocks also rose.

Mom and Pop Pile Into Hong Kong IPOs With $163 Billion Bonanza - Bloomberg

2017-11-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (276-0)

Banks lead China stocks higher on financial deregulation

2017-11-13 themalaymailonline
Investors piled into financial stocks, betting Beijing’s move to widen foreign access to its giant financial sector would attract fresh foreign capital inflows, and push up the valuations of Chinese lenders, insurers and brokerages. — Reuters picSHANGHAI, Nov 13 — China stocks rose today morning, led by banks, as excitement over financial deregulation unveiled last week continued to boost sentiment, mitigating wider concerns about higher corporate borrowing costs amid rising bond yields.

Jones Day welcomes M&A partner Charles Chau in Hong Kong

2017-08-16 marketwired
HONG KONG, CHINA--(Marketwired - Aug 16, 2017) - The global law firm Jones Day has announced that Charles Chau has joined the Firm's Hong Kong Office as a partner in its M&A Practice.

Exclusive: U.S. Cardinal Health puts $1.5 billion China business on block - sources

2017-07-20 reuters
HONG KONG (Reuters) - U.S. drug distributor Cardinal Health has put its China business up for sale, drawing keen interest from state-backed Chinese pharmaceutical firms in a deal that may be worth up to $1.5 billion, sources familiar with the matter said.

The hammer and sickle are making their way into some Hong Kong public companies

2017-05-30 scmp
As many as 19 Chinese state companies listed on the Hong Kong Stock Exchange have established Communist Party committees. Whose rules do they hew to?

GynTect soon available in China

2017-04-05 marketwired
oncgnostics grants exclusive license for GynTect to the Chinese SINOPHARM subsidiary CJMT; Approval for the Chinese market planned

China H-Share Rally Falters as Inflation Fuels Liquidity Concern - Bloomberg

2017-02-14 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

China pharmacies urge abolition of Alibaba Health drug tracking platform

2016-02-24 channelnewsasia
A group of Chinese pharmacy chains has demanded the abolition of a medicine tracking platform run by Alibaba Health Information Technology, piling further pressure on the firm after China's drug regulator suspended the system on Saturday.

China pharmacies urge abolition of Alibaba Health drug tracking platform

2016-02-24 reuters
SHANGHAI A group of Chinese pharmacy chains has demanded the abolition of a medicine tracking platform run by Alibaba Health Information Technology, piling further pressure on the firm after China's drug regulator suspended the system on Saturday.